Back |
home / stock / clxt / clxt message board
Subject | By | Source | When |
---|---|---|---|
* * $CLXT Video Chart 12-03-2019 * * | ClayTrader | investorshub | 12/03/2019 11:26:36 PM |
I don't like being a minority shareholder, so | DewDiligence | investorshub | 04/11/2018 10:09:14 PM |
Looks like $CLXT was on the way down | birdguy | investorshub | 04/11/2018 10:06:20 PM |
CLXT -3% on $MON tie-up with gene-editing company: | DewDiligence | investorshub | 03/20/2018 4:01:20 PM |
GMOs that are not GMOsor are they? | DewDiligence | investorshub | 12/19/2017 7:54:40 PM |
$CLXT advances two programs to phase-1: | DewDiligence | investorshub | 09/25/2017 9:07:27 PM |
$10.75 today. Looking for a run next | dinosaurbob | investorshub | 07/25/2017 9:14:08 PM |
https://finance.yahoo.com/news/why-genocea-biosciences-gnca-stock-205508283.html | GTrades17 | investorshub | 07/23/2017 7:36:07 PM |
Bought in at $10.00. I think this | dinosaurbob | investorshub | 07/23/2017 7:21:39 AM |
CLLS IPOs 8.05M* Calyxt (CLXT) shares @$8.00: | DewDiligence | investorshub | 07/20/2017 2:32:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Shares of Calyxt, Inc. (NASDAQ: CLXT) traded at a new 52-week high today and are currently trading at $5.4. So far today, approximately 55,181 shares have been exchanged, as compared to an average 30-day volume of 89,248 shares. Calyxt, Inc., a synthetic biology company, engages in delivering...
Calyxt Announces Stockholder Approval of Merger With Cibus PR Newswire -- Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock -- ROSEVILLE, Minn. , May 19, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announc...
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire —P roposed merger with Cibus Global Expected to Close in Q2 2023 — —1-for-10 reverse stock split executed— —Current customer...